Ahmed Karam Helmy
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes (NCT07321067) | Ahmed Karam Helmy | 2026-01-01 |
Track Ahmed Karam Helmy automatically
Every clearance here is in the API, with alerts when new ones post.